PTX3 and neoplasm: In vivo, when grafted into immunocompromised mice, PTX3 downregulation resulted in increased tumor burden of RT4-shPTX3 lesions when compared to control and wild-type tumors, accompanied by an increased proliferation index as assessed by immunostaining for phospho-histone H3-positive (pHH3+) cells (Figure 2G).